Considering that the numbers of IL-22+ CD4+ T cells were increased in COVID-19 patients and that IL-22R1-expressing cells may induce a positive auto-regulatory loop with IL-22 expression (20), the IL-22R1 expression was investigated on PBMC in parallel to the functional evaluation of the CD4+ lymphocytes. This evidence concerns the gene IL22RA1 and COVID-19.